Welcome to PERMEPSY
International project dedicated to establishing a personalized approach to psychological treatment for psychosis.
About project
PERMEPSY is a three-year project coordinated by the Parc Sanitari Sant Joan de Déu composed of 5 clinical partners from 5 different countries (Spain, Germany, France, Poland, and Chile) and one technological team (Spain). The aim of PERMEPSY (Personalised Medicine approach to psychological treatment for Psychosis) is to offer personalised delivery of Metacognitive Training (MCT) for people with psychosis.
Research team
Our consortium relies on a multidisciplinary team that includes experts in clinical psychology, psychiatry, computer science and artificial intelligence, molecular biology, and statistics. The clinical partners (coordinators FJSD, and partners UKE, UHS, PAoS, and UV) have collaborated throughout the years to develop MCT strategies addressed to patients with psychosis in different stages of the disorder.
Updates
You will find updates here about our project. If you want to stay up-to-date, join our newsletter.
🎤 PERMEPSY at WMH2025 — V European Meeting on Women’s Mental Health, Psychosis and Gender
We’re proud to share that PERMEPSY was strongly represented at the V European Meeting on Women’s Mental Health, Psychosis and Gender, held at Hospital de la Santa Creu i
🧠 PERMEPSY at the Setmana de la Salut Mental 2025!
We’re delighted to share that PERMEPSY was well represented at the Setmana de la Salut Mental 2025 del Parc Sanitari Sant Joan de Déu held
🔬 New PERMEPSY Publication in European Psychiatric Association
We’re thrilled to share our latest open-access article: “MCT for psychosis: a systematic review and GRADE recommendations”🔗 Read here This work, led by the French